Promising Nanotechnology Approaches in Treatment of Autoimmune Diseases of Central Nervous System
Multiple sclerosis (MS) is a chronic, autoimmune, neurodegenerative disease of the central nervous system (CNS) that yields to neuronal axon damage, demyelization, and paralysis. Although several drugs were designed for the treatment of MS, with some of them being approved in the last few decades, t...
Main Authors: | Maria Chountoulesi, Costas Demetzos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/10/6/338 |
Similar Items
-
Nanotechnology: from In Vivo Imaging System to Controlled Drug Delivery
by: Maria Mir, et al.
Published: (2017-08-01) -
Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight
by: Humzah Jamshaid, et al.
Published: (2021-04-01) -
Emergent Nanotechnological Strategies for Systemic Chemotherapy against Melanoma
by: Jacinta Oliveira Pinho, et al.
Published: (2019-10-01) -
Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine–Combination Therapy
by: Saffiya Habib, et al.
Published: (2021-02-01) -
Applications of nanotechnology in drug delivery to the central nervous system
by: Majid Saeedi, et al.
Published: (2019-03-01)